114 related articles for article (PubMed ID: 15899779)
21. Prognostic significance of Bax and Fas ligand in erionite and asbestos induced Turkish malignant pleural mesothelioma.
Kokturk N; Firat P; Akay H; Kadilar C; Ozturk C; Zorlu F; Gungen Y; Emri S
Lung Cancer; 2005 Nov; 50(2):189-98. PubMed ID: 16043260
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.
Kröger N; Milde-Langosch K; Riethdorf S; Schmoor C; Schumacher M; Zander AR; Löning T
Clin Cancer Res; 2006 Jan; 12(1):159-68. PubMed ID: 16397038
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S
BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413
[TBL] [Abstract][Full Text] [Related]
24. Fas and Fas ligand as prognostic factors in human breast carcinoma.
Bebenek M; Duś D; Koźlak J
Med Sci Monit; 2006 Nov; 12(11):CR457-61. PubMed ID: 17072269
[TBL] [Abstract][Full Text] [Related]
25. Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate.
Steinert DM; Oyarzo M; Wang X; Choi H; Thall PF; Medeiros LJ; Raymond AK; Benjamin RS; Zhang W; Trent JC
Cancer; 2006 Apr; 106(7):1617-23. PubMed ID: 16518826
[TBL] [Abstract][Full Text] [Related]
26. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy.
Kwon GY; Ha H; Ahn G; Park SY; Huh SJ; Park W
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1150-6. PubMed ID: 17692475
[TBL] [Abstract][Full Text] [Related]
27. Association between Bcl-2 expression and tumor recurrence in cervical cancer: a matched case-control study.
Manusirivithaya S; Siriaunkgul S; Khunamornpong S; Sripramote M; Sampatanukul P; Tangjitgamol S; Srisomboon J
Gynecol Oncol; 2006 Aug; 102(2):263-9. PubMed ID: 16483641
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
29. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer.
Neri A; Marrelli D; Roviello F; DeMarco G; Mariani F; DeStefano A; Megha T; Caruso S; Corso G; Cioppa T; Pinto E
Breast Cancer Res Treat; 2006 Sep; 99(1):77-83. PubMed ID: 16541314
[TBL] [Abstract][Full Text] [Related]
30. Pitfalls in immunohistochemical validation of tumor marker expression--exemplified in invasive cancer of the uterine cervix.
Hellberg D; Tot T; Stendahl U
Gynecol Oncol; 2009 Jan; 112(1):235-40. PubMed ID: 18976801
[TBL] [Abstract][Full Text] [Related]
31. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma.
Elstrand MB; Kleinberg L; Kohn EC; Tropé CG; Davidson B
Int J Gynecol Pathol; 2009 May; 28(3):211-21. PubMed ID: 19620938
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract.
Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E
Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504
[TBL] [Abstract][Full Text] [Related]
33. Fas expression is associated with a better prognosis in laryngeal squamous cell carcinoma.
Asensio C; Zapata A; García-Ahijado J; Gil B; Salvadores P; Schneider J
Anticancer Res; 2007; 27(6B):4083-6. PubMed ID: 18225575
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma.
Chen MK; Lai JC; Chang CC; Chang JH; Chang YJ; Chen HC
Head Neck; 2008 Aug; 30(8):1052-7. PubMed ID: 18442057
[TBL] [Abstract][Full Text] [Related]
35. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 expression is a prognostic factor in the subgroups of patients with colorectal cancer.
Sun XF; Bartik Z; Zhang H
Int J Oncol; 2003 Nov; 23(5):1439-43. PubMed ID: 14532988
[TBL] [Abstract][Full Text] [Related]
37. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of dysadherin expression in patients with non-small cell lung cancer.
Tamura M; Ohta Y; Tsunezuka Y; Matsumoto I; Kawakami K; Oda M; Watanabe G
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):740-5. PubMed ID: 16153922
[TBL] [Abstract][Full Text] [Related]
39. Expression of Fas ligand (CD95L) in primary malignant melanoma and melanoma metastases is associated with overall survival.
Neuber K; Eidam B
Onkologie; 2006 Sep; 29(8-9):361-5. PubMed ID: 16974112
[TBL] [Abstract][Full Text] [Related]
40. Expression of the bcl-2 gene and its significance in human pancreatic carcinoma.
Sun CY; Wang BL; Hu CQ; Peng RY; Gao YB; Gu QY; Wang DW
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):306-8. PubMed ID: 14612291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]